Miran Šebeštjen

机构：University of Ljubljana, Ljubljana University Medical Centre, Medical University of Vienna · ORCID：0000-0001-9907-3522

发表论文 126 篇 · 总被引 1283 次 · h-index 20

代表论文

Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values (2024 · International Journal of Molecular Sciences · 被引 6)
Treatment with PCSK9 inhibitors influences microRNAs expression and changes of arterial wall properties: a randomized controlled trial (2025 · European journal of medical research · 被引 2)
Effect of PCSK9 Inhibitors on Regulators of Lipoprotein Homeostasis, Inflammation and Coagulation (2025 · Biomedicines · 被引 2)
Effects of proprotein convertase subtilisin-kexin type 9 inhibitors on inflammatory and hemostatic parameters in post myocardial infarction patients (2023 · European Journal of Pharmacology · 被引 2)
Proprotein convertase subtilisin/kexin type 9–CC-motif chemokine ligand 2 interactions link lipoprotein(a) composition to intermediate monocyte inflammation in coronary artery disease (2026 · Atherosclerosis Plus · 被引 1)
Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection Fraction (2025 · Journal of Cardiovascular Development and Disease · 被引 1)